Literature DB >> 9189631

Antibiotic resistance: an ecological imbalance.

S B Levy1.   

Abstract

Antibiotic resistance thwarts the treatment of infectious diseases worldwide. Although a number of factors can be identified which contribute to the problem, clearly the antibiotic as a selective agent and the resistance gene as the vehicle of resistance are the two most important, making up a 'drug resistance equation'. Both are needed in order for a clinical problem to arise. Given sufficient time and quantity of antibiotic, drug resistance will eventually appear. But a public health problem is not inevitable if the two components of the drug resistance equation are kept in check. Enhancing the emergence of resistance is the case by which resistance determinants and resistant bacteria can spread locally and globally, selected by widespread use of the same antibiotics in people, animal husbandry and agriculture. Antibiotics are societal drugs. Each individual use contributes to the sum total of society's antibiotic exposure. In a broader sense, the resistance problem is ecological. In the framework of natural competition between susceptible and resistant bacteria, antibiotic use has encouraged growth of the resistant strains, leading to an imbalance in prior relationships between susceptible and resistant bacteria. To restore efficacy to earlier antibiotics and to maintain the success of new antibiotics that are introduced, we need to use antibiotics in a way which assures an ecological balance that favours the predominance of susceptible bacterial flora.

Entities:  

Mesh:

Year:  1997        PMID: 9189631     DOI: 10.1002/9780470515358.ch1

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  23 in total

1.  Adherence and drug resistance: predictions for therapy outcome.

Authors:  L M Wahl; M A Nowak
Journal:  Proc Biol Sci       Date:  2000-04-22       Impact factor: 5.349

2.  Antimicrobial resistance - Judicious use is the key.

Authors:  John M Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-09       Impact factor: 2.471

3.  Canadian Committee on Antibiotic Resistance report.

Authors:  John M Conly; Scott McEwen; Jim Hutchinson; Nora Boyd; Sandra Callery; Elizabeth Bryce
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-09       Impact factor: 2.471

4.  Strategies of maintaining the natural purification potential of rivers and lakes.

Authors:  Ursula Obst
Journal:  Environ Sci Pollut Res Int       Date:  2003       Impact factor: 4.223

Review 5.  Antimicrobial resistance in Canada.

Authors:  John Conly
Journal:  CMAJ       Date:  2002-10-15       Impact factor: 8.262

6.  Antibiotic multiresistance analysis of mesophilic and psychrotrophic Pseudomonas spp. isolated from goat and lamb slaughterhouse surfaces throughout the meat production process.

Authors:  Leyre Lavilla Lerma; Nabil Benomar; María del Carmen Casado Muñoz; Antonio Gálvez; Hikmate Abriouel
Journal:  Appl Environ Microbiol       Date:  2014-08-29       Impact factor: 4.792

7.  Quantifying the associations between antibiotic exposure and resistance - a step towards personalised antibiograms.

Authors:  L Sanden; M Paul; L Leibovici; S Andreassen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-08-26       Impact factor: 3.267

8.  Predicting community dynamics of antibiotic-sensitive and -resistant species in fluctuating environments.

Authors:  Olga A Nev; Alys Jepson; Robert E Beardmore; Ivana Gudelj
Journal:  J R Soc Interface       Date:  2020-05-27       Impact factor: 4.118

9.  Standardization of broth microdilution and disk diffusion susceptibility tests for Actinobacillus pleuropneumoniae and Haemophilus somnus: quality control standards for ceftiofur, enrofloxacin, florfenicol, gentamicin, penicillin, tetracycline, tilmicosin, and trimethoprim-sulfamethoxazole.

Authors:  P F McDermott; A L Barry; R N Jones; G E Stein; C Thornsberry; C C Wu; R D Walker
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

10.  Effect of Lactobacillus acidophilus and Bifidobacterium bifidum supplementation to standard triple therapy on Helicobacter pylori eradication and dynamic changes in intestinal flora.

Authors:  Yu-huan Wang; Ying Huang
Journal:  World J Microbiol Biotechnol       Date:  2014-03       Impact factor: 3.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.